Neuroleptic therapy following neuroleptic malignant syndrome.
D000328:Adult; D004359:Drug Therapy, Combination; D006220:Haloperidol / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology*; D010546:Perphenazine / Q000627:therapeutic use*; D011618:Psychotic Disorders / Q000188:drug therapy*; D013888:Thiothixene / Q000009:adverse effects* / Q000627:therapeutic use
D013888:Thiothixene; D010546:Perphenazine; D006220:Haloperidol